eCFR Reference Browser

---

title: "21 CFR §610.17"

source: "https://www.ecfr.gov/current/title-21/section-610.17"

title_number: "21"

volume_number: "7"

chapter_number: "Unknown"

subchapter_code: "F"

subchapter_subject: "BIOLOGICS"

part_code: "610"

part_subject: "GENERAL BIOLOGICAL PRODUCTS STANDARDS"

subpart_code: "B"

subpart_subject: "General Provisions"

section_number: "610.17"

section_subject: "Permissible combinations."

cfr_reference: "21 CFR 610.17"

title_name: "Title 21"

title_subject: "Food and Drugs"

parts_covered: "Parts 600 to 799"

revised_date: "Revised as of April 1, 2019"

publication_date: "As of April 1, 2019"

contains_description: "Containing a codification of documents of general applicability and future effect"

publication_info: "Published by the Office of the Federal Register National Archives and Records Administration as a Special Edition of the Federal Register"

---

Licensed products may not be combined with other licensed products either therapeutic, prophylactic or diagnostic, except as a license is obtained for the combined product. Licensed products may not be combined with nonlicensable therapeutic, prophylactic, or diagnostic substances except as a license is obtained for such combination.

§610.17 - Permissible combinations.